BRPI1013410A2 - processos de pcr para a caracterização da região não traduzida a 5' dos genes fmr1 e fmr2 - Google Patents

processos de pcr para a caracterização da região não traduzida a 5' dos genes fmr1 e fmr2

Info

Publication number
BRPI1013410A2
BRPI1013410A2 BRPI1013410A BRPI1013410A BRPI1013410A2 BR PI1013410 A2 BRPI1013410 A2 BR PI1013410A2 BR PI1013410 A BRPI1013410 A BR PI1013410A BR PI1013410 A BRPI1013410 A BR PI1013410A BR PI1013410 A2 BRPI1013410 A2 BR PI1013410A2
Authority
BR
Brazil
Prior art keywords
fmr1
untranslated region
characterization
pcr processes
region
Prior art date
Application number
BRPI1013410A
Other languages
English (en)
Inventor
J Latham Gary
Chen Liangjing
Sah Sachin
Original Assignee
Asuragen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asuragen Inc filed Critical Asuragen Inc
Publication of BRPI1013410A2 publication Critical patent/BRPI1013410A2/pt
Publication of BRPI1013410B1 publication Critical patent/BRPI1013410B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6858—Allele-specific amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

processos de pcr para a caracterização da região não traduzida a 5' dos genes fmr1 e fmr2 a presente invenção refere-se a processos de determinação da presença e da posição de agg ou elementos de interrupção dentro de uma região de repetição com três nucleotídeos (por exemplo, cgg) e a processos de determinação do número de repetições presentes nesta região, através da amplificação de um conjunto de produtos com um conjunto de iniciadores do qual pelo menos um compreende uma parte da região de repetição de cgg e da resolução dos produtos para produzir uma representação de tamanho e abundância do produto .
BRPI1013410-7A 2009-03-24 2010-02-16 Método de analisar se uma sequência de interrupção está presente em pelo menos uma região rica em cgg compreendida por pelo menos um molde em uma amostra BRPI1013410B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16297709P 2009-03-24 2009-03-24
US61/162,977 2009-03-24
PCT/US2010/000426 WO2010110835A1 (en) 2009-03-24 2010-02-16 Pcr methods for characterizing the 5' untranslated region of the fmr1 and fmr2 genes

Publications (2)

Publication Number Publication Date
BRPI1013410A2 true BRPI1013410A2 (pt) 2019-07-02
BRPI1013410B1 BRPI1013410B1 (pt) 2020-10-06

Family

ID=42313963

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1013410-7A BRPI1013410B1 (pt) 2009-03-24 2010-02-16 Método de analisar se uma sequência de interrupção está presente em pelo menos uma região rica em cgg compreendida por pelo menos um molde em uma amostra

Country Status (12)

Country Link
US (2) US8679757B2 (pt)
EP (1) EP2411532B1 (pt)
KR (1) KR20110138387A (pt)
CN (2) CN102449171B (pt)
AU (1) AU2010229334B2 (pt)
BR (1) BRPI1013410B1 (pt)
ES (1) ES2629400T3 (pt)
HK (1) HK1220988A1 (pt)
IL (1) IL215296A (pt)
RU (1) RU2011142773A (pt)
WO (1) WO2010110835A1 (pt)
ZA (1) ZA201107298B (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ584793A (en) 2007-10-26 2012-05-25 Academisch Ziekenhuis Leiden Means and methods for counteracting muscle disorders
EP2119783A1 (en) 2008-05-14 2009-11-18 Prosensa Technologies B.V. Method for efficient exon (44) skipping in Duchenne Muscular Dystrophy and associated means
EP2285979B2 (en) 2008-05-27 2020-02-19 Dako Denmark A/S Hybridization compositions and methods
WO2010097656A1 (en) 2009-02-26 2010-09-02 Dako Denmark A/S Compositions and methods for performing a stringent wash step in hybridization applications
EP2488665B1 (en) 2009-10-16 2017-12-13 National University of Singapore Screening method for trinucleotide repeat sequences
EP3056574B1 (en) * 2010-02-05 2018-08-22 Quest Diagnostics Investments Incorporated Method to detect repeat sequence motifs in nucleic acid
WO2012047970A1 (en) * 2010-10-05 2012-04-12 Board Of Trustees Of Michigan State University Regulatory factors controlling oil biosynthesis in microalgae and their use
AU2011320359B2 (en) 2010-10-29 2015-07-16 Asuragen, Inc. mPCR methods for analyzing repeat sequences
WO2013046033A1 (en) 2011-09-30 2013-04-04 Dako Denmark A/S Hybridization compositions and methods using formamide
WO2013057310A2 (en) * 2011-10-21 2013-04-25 Dako Denmark A/S Hybridization compositions and methods
WO2014015273A1 (en) * 2012-07-20 2014-01-23 Asuragen, Inc. Comprehensive fmr1 genotyping
EP2992083A4 (en) * 2013-05-01 2017-02-08 Advanced Liquid Logic, Inc. Analysis of dna
CA2929249A1 (en) 2013-11-13 2015-05-21 Counsyl, Inc. Automated nucleic acid repeat count calling methods
WO2017015543A1 (en) * 2015-07-23 2017-01-26 Asuragen, Inc. Methods, compositions, kits, and uses for analysis of nucleic acids comprising repeating a/t-rich segments
KR20180064544A (ko) 2015-11-03 2018-06-14 아수라겐, 인크. 반복부 서열의 핵산 크기 검출 방법
RU2620944C1 (ru) * 2016-12-27 2017-05-30 Федеральное государственное бюджетное научное учреждение "Научный центр неврологии" (ФГБНУ НЦН) Способ выявления экспансии тринуклеотидных CGG-повторов в 5'-нетранслируемой, промоторной области гена FMR1 при заболевании синдрома атаксии/тремора, ассоциированного с ломкой Х-хромосомы (FXTAS)
CN108866176B (zh) * 2017-07-11 2021-09-14 北京阅微基因技术股份有限公司 一种对fmr1基因5’非翻译区cgg单元重复数量的检测体系及检测试剂盒
CN107523621A (zh) * 2017-09-04 2017-12-29 广州市达瑞生物技术股份有限公司 一种用于检测脆性x综合征的引物组及其试剂盒
CA3130854A1 (en) * 2019-02-26 2020-09-03 Nogra Pharma Limited Fragile x mental retardation protein interfering oligonucleotides and methods of using same
CN110157782A (zh) * 2019-03-08 2019-08-23 北京华瑞康源生物科技发展有限公司 一种用于快速检测fmr1基因cgg重复序列的引物群及pcr试剂盒
CN110577987B (zh) * 2019-06-24 2023-08-25 厦门百欧迅生物科技有限公司 一种fmr1基因cgg重复序列的检测方法及其应用
CN113215228A (zh) * 2021-02-07 2021-08-06 迈基诺（重庆）基因科技有限责任公司 脆性x综合征fmr1基因检测引物、试剂盒及其应用
US20230407398A1 (en) * 2022-02-09 2023-12-21 Laboratory Corporation Of America Holdings Methods and Systems for Detecting Methylation of Fragile X

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
FR2672618B1 (fr) 1991-02-13 1994-12-02 Centre Nat Rech Scient Fragment d'acide nucleique de la region du chromosome x implique dans le syndrome x fragile, sonde nucleotidique et procede pour le diagnostic du retard mental avec x fragile.
WO1992014840A1 (fr) 1991-02-13 1992-09-03 Institut National De La Sante Et De La Recherche Medicale Fragment d'acide nucleique de la region du chromosome x implique dans le syndrome x fragile, sonde nucleotidique et procede pour le diagnostic du retard mental avec x fragile
US6200747B1 (en) 1992-01-28 2001-03-13 North Shore University Hospital Research Corp. Method and kits for detection of fragile X specific, GC-rich DNA sequences
US5648211A (en) 1994-04-18 1997-07-15 Becton, Dickinson And Company Strand displacement amplification using thermophilic enzymes
US5976842A (en) 1997-10-30 1999-11-02 Clontech Laboratories, Inc. Methods and compositions for use in high fidelity polymerase chain reaction
JP2002525049A (ja) 1998-09-15 2002-08-13 イェール ユニバーシティ ローリングサークル増幅を用いる分子クローニング
US6143504A (en) 1998-10-27 2000-11-07 Arch Development Corporation Methods and compositions for the diagnosis of fragile X syndrome
ATE374833T1 (de) 1998-11-09 2007-10-15 Eiken Chemical Verfahren zur synthese von nukleinsäuren
US6335165B1 (en) 1999-01-25 2002-01-01 Gamidagen Ltd. Methods and kits for characterizing GC-rich nucleic acid sequences
US6326173B1 (en) 1999-04-12 2001-12-04 Nanogen/Becton Dickinson Partnership Electronically mediated nucleic acid amplification in NASBA
EP1088891B1 (en) 1999-09-28 2005-01-12 Roche Diagnostics GmbH Thermostable enzyme promoting the fidelity of thermostable DNA polymerases - for improvement of nucleic acid synthesis and amplification in vitro
US6670124B1 (en) 1999-12-20 2003-12-30 Stemcyte, Inc. High throughput methods of HLA typing
JP2001269188A (ja) 2000-03-11 2001-10-02 Roche Diagnostics Gmbh Ｐｃｒにおける性能が向上したｂ型ｄｎａポリメラーゼ変異体
WO2004110246A2 (en) * 2003-05-15 2004-12-23 Illumina, Inc. Methods and compositions for diagnosing conditions associated with specific dna methylation patterns
US7855053B2 (en) 2006-07-19 2010-12-21 The Regents Of The University Of California Methods for detecting the presence of expanded CGG repeats in the FMR1 gene 5′ untranslated region
US8163480B2 (en) 2006-10-05 2012-04-24 Quest Diagnostics Investments Incorporated Nucleic acid size detection method
US8409805B2 (en) 2009-02-13 2013-04-02 Asuragen, Inc. Method of amplification of GC-rich DNA templates

Also Published As

Publication number Publication date
US20100243451A1 (en) 2010-09-30
EP2411532A1 (en) 2012-02-01
US8679757B2 (en) 2014-03-25
KR20110138387A (ko) 2011-12-27
US20140248625A1 (en) 2014-09-04
CN105296474A (zh) 2016-02-03
RU2011142773A (ru) 2013-04-27
IL215296A0 (en) 2011-12-29
WO2010110835A1 (en) 2010-09-30
AU2010229334B2 (en) 2015-08-20
US9783848B2 (en) 2017-10-10
BRPI1013410B1 (pt) 2020-10-06
IL215296A (en) 2016-08-31
AU2010229334A1 (en) 2011-10-20
CN102449171A (zh) 2012-05-09
HK1220988A1 (zh) 2017-05-19
CN105296474B (zh) 2020-05-12
ES2629400T3 (es) 2017-08-09
EP2411532B1 (en) 2017-04-05
ZA201107298B (en) 2018-11-28
CN102449171B (zh) 2015-12-02

Similar Documents

Publication Publication Date Title
BRPI1013410A2 (pt) processos de pcr para a caracterização da região não traduzida a 5' dos genes fmr1 e fmr2
BR112016019267A2 (pt) métodos e composições para perfil de dna
BR112018076190A2 (pt) ortólogos e sistemas crispr tipo vi
EP4269616A3 (en) Accurate molecular barcoding
WO2010045318A3 (en) Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type
BR112017016080A2 (pt) polinucleotídeo, sistema crispr, dois polinucleotídeos e métodos de modificação de uma molécula, de redução de modificação fora do alvo e de aumento da modificação específica de alvo
WO2015130968A3 (en) T cell balance gene expression, compositions of matters and methods of use thereof
EP2340314A4 (en) OBTAINING INFORMATION RELATED TO GENOMIC DNA METHYLATION
WO2008086079A3 (en) Compositions comprising rnai and a neurotrophic factor and uses thereof
WO2008073919A3 (en) Mir-20 regulated genes and pathways as targets for therapeutic intervention
WO2015119941A3 (en) Genome fractioning
BR112012009144A2 (pt) métodos e sistemas para tratamento farmacogenômico de condições cardiovasculares
NZ701145A (en) Compositions and methods for quantifying a nucleic acid sequence in a sample
EP4293125A3 (en) Methods for targeted genomic analysis
WO2016138488A3 (en) T cell balance gene expression, compositions of matters and methods of use thereof
WO2012109500A3 (en) Analysis of nucleic acids
BR112019005548A2 (pt) tratamento da doença de huntington com aav
WO2006138606A3 (en) Cell signaling genes and related methods
WO2007104318A3 (en) Oligonucleotides comprising signalling pairs and hydrophobic nucleotides, stemless beacons, for detection of nucleic acids, methylation status and mutants of nucleic acids
BR112016011840A2 (pt) método para tipificação de dna de um gene hla, e, conjunto de iniciadores
BRPI0816047A2 (pt) conjunto de oligonucleotídeos para detecção de um ácido nucleico alvo, métodos para detecção da presença ou ausência de um ácido nucleico alvo e de pelo menos dois ácidos nucleicos alvo, kit, mistura de reação e amplicon identificado por fluorescência
EA201270607A1 (ru) Аденовирус обезьян и способы его использования
WO2008073921A3 (en) Mir-126 regulated genes and pathways as targets for therapeutic intervention
BR112014021993B8 (pt) "métodos para detecção de uma variação de nucleotídeo em uma sequência de ácido nucleico alvo através de um ensaio de ptoce"
BR112018015155A2 (pt) métodos para determinação da presença ou ausência de um micro-organismo em uma amostra, para testar rapidamente uma matriz alimentar e um micro-organismo alvo, e, composição.

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/10/2020, OBSERVADAS AS CONDICOES LEGAIS.